Amoxapine

Amoxapine is classified as a second-generation tricyclic dibenzoxazepine antidepressant approved by the U.S. Food and Drug Administration (FDA). This medication is typically prescribed for managing treatment-resistant or persistent depression. Amoxapine is indicated for use in cases of depression accompanied by other psychiatric issues such as anxiety, agitation, psychosis, neurosis, or recurrent depression. The objective of this activity is to familiarize medical practitioners with the appropriate usage of amoxapine and its dosing guidelines, administration, monitoring instructions, and the adverse effects associated with this drug. This activity also highlights the critical roles of a unified interprofessional team in the treatment of patients using amoxapine for their depression.